Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement of Nile Therapeutics, Inc. on Form S-1 of our report dated March 14, 2011, on the financial statements of Nile Therapeutics, Inc. and to the reference to us under the heading “Experts” in the prospectus.
/s/ Crowe Horwath LLP
New York, New York
July 22, 2011